# Pravastatin and Protease Inhibitors in HIV-Infected Patients

> **NCT00221754** · PHASE2 · COMPLETED · sponsor: **University Hospital, Bordeaux** · enrollment: 21 (actual)

## Conditions studied

- HIV Infection
- Hypercholesterolemia

## Interventions

- **DRUG:** Pravastatin (drug)

## Key facts

- **NCT ID:** NCT00221754
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** —
- **Final completion:** 2004-03
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2007-06-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00221754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00221754, "Pravastatin and Protease Inhibitors in HIV-Infected Patients". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00221754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*